Parabilis Medicines Quarterly Balance Sheet
NASDAQ: PBLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Parabilis Medicines financial position
As of Jun 30, 2026, Parabilis Medicines reported total assets of $1.18 billion against total liabilities of $127.5 million. Shareholders' equity stood at $1.05 billion, or 89.1% of assets. The company held $1.09 billion in cash and equivalents against $6.4 million of debt, a net cash position of $1.08 billion.
The current ratio (current assets divided by current liabilities) was 17.91, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.01.
Summary generated from market data by MetaCap's automated system. Methodology
Parabilis Medicines balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q? 20262026-03-31 | Q? 20252025-06-30 | Q? 20252025-03-31 |
|---|---|---|---|---|
| Cash & Equivalents | 1.09B | — | 80.39M | — |
| Short-Term Investments | 33.64M | — | — | — |
| Total Current Assets | 1.13B | — | — | — |
| Property, Plant & Equipment | 6.72M | — | — | — |
| Total Assets | 1.18B | — | — | — |
| Accounts Payable | 18.52M | — | — | — |
| Short-Term Debt | 5.71M | — | — | — |
| Total Current Liabilities | 62.84M | — | — | — |
| Long-Term Debt | 700.00K | — | — | — |
| Total Liabilities | 127.53M | — | — | — |
| Shareholders' Equity | 1.05B | -570.32M | -455.41M | -421.43M |
| Retained Earnings | -639.28M | — | — | — |
| Total Debt | 6.41M | — | — | — |
| Net Cash (Debt) | 1.11B | — | 80.39M | — |
| Shares Outstanding | 121.94M | — | — | — |
This table shows 4 quarterly periods of Parabilis Medicines's balance sheet, from Q2 2026 back to Q? 2025, across 15 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow PBLS's reporting calendar. What is a balance sheet?